12 results
10-K
2020 FY
ONCR
Oncorus, Inc.
10 Mar 21
Annual report
4:12pm
immunotherapy, cell and gene therapy and regenerative medicine. Dr. Finer previously served as our chief executive officer and chief scientific officer
424B4
ONCR
Oncorus, Inc.
12 Feb 21
Prospectus supplement with pricing info
4:23pm
decades of experience in cancer immunotherapy, cell and gene therapy and regenerative medicine. Dr. Finer previously served as our chief executive … of experience in cancer immunotherapy, cell and gene therapy and regenerative medicine. Dr. Finer previously served as our chief executive officer
DRS
ONCR
Oncorus, Inc.
28 Jan 21
Draft registration statement
12:00am
of experience in cancer immunotherapy, cell and gene therapy and regenerative medicine. Dr. Finer previously served as our chief executive officer … immunotherapy, cell and gene therapy and regenerative medicine. Dr. Finer previously served as our chief executive officer and chief scientific
424B4
x2qhik5dv9q 8qy
2 Oct 20
Prospectus supplement with pricing info
12:00am
S-1
euhzr8w6fk2dnjnao608
11 Sep 20
IPO registration
4:49pm
DRS/A
51r lq7qa3ownb0o9qi
26 Aug 20
Draft registration statement (amended)
12:00am
DRS/A
ni47rrgb
29 Jul 20
Draft registration statement (amended)
12:00am
DRS/A
acm74d0ye76s m8
20 Dec 19
Draft registration statement (amended)
12:00am
DRS
scp7vnli 8uoz
31 Oct 19
Draft registration statement
12:00am
- Prev
- 1
- Next